Helicobacter pylori Pathogen-Associated Molecular Patterns: Friends or Foes?
Abstract
:1. Introduction
2. Lipopolysaccharide
3. Metabolites
3.1. HBP and ADP-Heptose
3.2. Cholesterol Derivatives
4. Bacterial Proteins and Peptides
4.1. Flagellin
4.2. Hp(2-20) Peptide
5. Extracellular DNA and RNA
6. Outer Membrane Vesicles
7. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Janeway, C.A., Jr. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb. Symp. Quant. Biol. 1989, 54 Pt 1, 1–13. [Google Scholar] [CrossRef] [PubMed]
- Medzhitov, R. Pattern recognition theory and the launch of modern innate immunity. J. Immunol. 2013, 191, 4473–4474. [Google Scholar] [CrossRef] [PubMed]
- Mezmale, L.; Coelho, L.G.; Bordin, D.; Leja, M. Review: Epidemiology of Helicobacter pylori. Helicobacter 2020, 25 (Suppl. S1), e12734. [Google Scholar] [CrossRef] [PubMed]
- Algood, H.M.; Cover, T.L. Helicobacter pylori persistence: An overview of interactions between H. pylori and host immune defenses. Clin. Microbiol. Rev. 2006, 19, 597–613. [Google Scholar] [CrossRef] [Green Version]
- Bagheri, N.; Azadegan-Dehkordi, F.; Shirzad, H.; Rafieian-Kopaei, M.; Rahimian, G.; Razavi, A. The biological functions of IL-17 in different clinical expressions of Helicobacter pylori-infection. Microb. Pathog. 2015, 81, 33–38. [Google Scholar] [CrossRef]
- Adamsson, J.; Ottsjö, L.S.; Lundin, S.B.; Svennerholm, A.M.; Raghavan, S. Gastric expression of IL-17A and IFNγ in Helicobacter pylori infected individuals is related to symptoms. Cytokine 2017, 99, 30–34. [Google Scholar] [CrossRef]
- Abadi, A.T.B. Strategies used by Helicobacter pylori to establish persistent infection. World J. Gastroenterol. 2017, 23, 2870–2882. [Google Scholar] [CrossRef]
- Gobert, A.P.; McGee, D.J.; Akhtar, M.; Mendz, G.L.; Newton, J.C.; Cheng, Y.; Mobley, H.L.; Wilson, K.T. Helicobacter pylori arginase inhibits nitric oxide production by eukaryotic cells: A strategy for bacterial survival. Proc. Natl. Acad. Sci. USA 2001, 98, 13844–13849. [Google Scholar] [CrossRef] [Green Version]
- Lekmeechai, S.; Su, Y.C.; Brant, M.; Alvarado-Kristensson, M.; Vallström, A.; Obi, I.; Arnqvist, A.; Riesbeck, K. Helicobacter pylori outer membrane vesicles protect the pathogen from reactive oxygen species of the respiratory burst. Front. Microbiol. 2018, 9, 1837. [Google Scholar] [CrossRef] [Green Version]
- Nguyen, G.T.; Green, E.R.; Mecsas, J. Neutrophils to the ROScue: Mechanisms of NADPH oxidase activation and bacterial resistance. Front. Cell Infect. Microbiol. 2017, 7, 373. [Google Scholar] [CrossRef]
- Chaturvedi, R.; Cheng, Y.; Asim, M.; Bussière, F.I.; Xu, H.; Gobert, A.P.; Hacker, A.; Casero, R.A., Jr.; Wilson, K.T. Induction of polyamine oxidase 1 by Helicobacter pylori causes macrophage apoptosis by hydrogen peroxide release and mitochondrial membrane depolarization. J. Biol. Chem. 2004, 279, 40161–40173. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Calvino-Fernández, M.; Benito-Martínez, S.; Parra-Cid, T. Oxidative stress by Helicobacter pylori causes apoptosis through mitochondrial pathway in gastric epithelial cells. Apoptosis 2008, 13, 1267–1280. [Google Scholar] [CrossRef] [PubMed]
- Otani, K.; Tanigawa, T.; Watanabe, T.; Nadatani, Y.; Sogawa, M.; Yamagami, H.; Shiba, M.; Watanabe, K.; Tominaga, K.; Fujiwara, Y.; et al. Toll-like receptor 9 signaling has anti-inflammatory effects on the early phase of Helicobacter pylori-induced gastritis. Biochem. Biophys. Res. Commun. 2012, 426, 342–349. [Google Scholar] [CrossRef] [PubMed]
- Caroff, M.; Novikov, A. LPS Structure, Function, and Heterogeneity. In Endotoxin Detection and Control in Pharma, Limulus, and Mammalian Systems; Williams, K., Ed.; Springer: Cham, Switzerland, 2019; pp. 53–93. [Google Scholar] [CrossRef]
- Needham, B.D.; Trent, M.S. Fortifying the barrier: The impact of lipid A remodelling on bacterial pathogenesis. Nat. Rev. Microbiol. 2013, 11, 467–481. [Google Scholar] [CrossRef] [PubMed]
- Stead, C.M.; Beasley, A.; Cotter, R.J.; Trent, M.S. Deciphering the unusual acylation pattern of Helicobacter pylori lipid A. J. Bacteriol. 2008, 190, 7012–7021. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Facchini, F.A.; Zaffaroni, L.; Minotti, A.; Rapisarda, S.; Calabrese, V.; Forcella, M.; Fusi, P.; Airoldi, C.; Ciaramelli, C.; Billod, J.M.; et al. Structure-Activity Relationship in Monosaccharide-Based Toll-Like Receptor 4 (TLR4) Antagonists. J. Med. Chem. 2018, 61, 2895–2909. [Google Scholar] [CrossRef] [Green Version]
- Tran, A.X.; Whittimore, J.D.; Wyrick, P.B.; McGrath, S.C.; Cotter, R.J.; Trent, M.S. The lipid A 1-phosphatase of Helicobacter pylori is required for resistance to the antimicrobial peptide polymyxin. J. Bacteriol. 2006, 188, 4531–4541. [Google Scholar] [CrossRef] [Green Version]
- Cullen, T.W.; Giles, D.K.; Wolf, L.N.; Ecobichon, C.; Boneca, I.G.; Trent, M.S. Helicobacter pylori versus the host: Remodeling of the bacterial outer membrane is required for survival in the gastric mucosa. PLoS Pathog. 2011, 7, e1002454. [Google Scholar] [CrossRef] [Green Version]
- Ishihara, S.; Rumi, M.A.K.; Kadowaki, Y.; Ortega-Cava, C.F.; Yuki, T.; Yoshino, N.; Miyaoka, Y.; Kazumori, H.; Ishimura, N.; Amano, Y.; et al. Essential role of MD-2 in TLR4-dependent signaling during Helicobacter pylori-associated gastritis. J. Immunol. 2004, 173, 1406–1416. [Google Scholar] [CrossRef] [Green Version]
- Sangwan, V.; Al-Marzouki, L.; Pal, S.; Stavrakos, V.; Alzahrani, M.; Antonatos, D.; Nevo, Y.; Camilleri-Broët, S.; Rayes, R.; Bourdeau, F.; et al. Inhibition of LPS-mediated TLR4 activation abrogates gastric adenocarcinoma-associated peritoneal metastasis. Clin. Exp. Metastasis 2021. [Google Scholar] [CrossRef]
- Yokota, S.; Ohnishi, T.; Muroi, M.; Tanamoto, K.; Fujii, N.; Amano, K. Highly-purified Helicobacter pylori LPS preparations induce weak inflammatory reactions and utilize Toll-like receptor 2 complex but not Toll-like receptor 4 complex. FEMS Immunol. Med. Microbiol. 2007, 51, 140–148. [Google Scholar] [CrossRef] [Green Version]
- Smith, S.M.; Moran, A.P.; Duggan, S.P.; Ahmed, S.E.; Mohamed, A.S.; Windle, H.J.; O’Neill, L.A.; Kelleher, D.P. Tribbles 3: A novel regulator of TLR2-mediated signaling in response to Helicobacter pylori lipopolysaccharide. J. Immunol. 2011, 186, 2462–2471. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Monteiro, M.A. Helicobacter pylori: A wolf in sheep’s clothing: The glycotype families of Helicobacter pylori lipopolysaccharides expressing histo-blood groups: Structure, biosynthesis, and role in pathogenesis. Adv. Carbohydr. Chem. Biochem. 2001, 57, 99–158. [Google Scholar] [CrossRef] [PubMed]
- Moran, A.P.; Prendergast, M.M. Molecular mimicry in Campylobacter jejuni and Helicobacter pylori lipopolysaccharides: Contribution of gastrointestinal infections to autoimmunity. J. Autoimmun. 2001, 16, 241–256. [Google Scholar] [CrossRef] [PubMed]
- Moran, A.P. Relevance of fucosylation and Lewis antigen expression in the bacterial gastroduodenal pathogen Helicobacter pylori. Carbohydr. Res. 2008, 343, 1952–1965. [Google Scholar] [CrossRef]
- Bergman, M.P.; Engering, A.; Smits, H.H.; van Vliet, S.J.; van Bodegraven, A.A.; Wirth, H.P.; Kapsenberg, M.L.; Vandenbroucke-Grauls, C.M.J.E.; van Kooyk, Y.; Appelmelk, B.J. Helicobacter pylori modulates the T helper cell 1/T helper cell 2 balance through phase-variable interaction between lipopolysaccharide and DC-SIGN. J. Exp. Med. 2004, 200, 979–990. [Google Scholar] [CrossRef]
- Lina, T.T.; Alzahrani, S.; Gonzalez, J.; Pinchuk, I.V.; Beswick, E.J.; Reyes, V.E. Immune evasion strategies used by Helicobacter pylori. World J. Gastroenterol. 2014, 20, 12753–12766. [Google Scholar] [CrossRef]
- Miszczyk, E.; Rudnicka, K.; Moran, A.P.; Fol, M.; Kowalewicz-Kulbat, M.; Druszczyńska, M.; Matusiak, A.; Walencka, M.; Rudnicka, W.; Chmiela, M. Interaction of Helicobacter pylori with C-type lectin dendritic cell-specific ICAM grabbing nonintegrin. J. Biomed. Biotechnol. 2012, 2012, 206463. [Google Scholar] [CrossRef] [Green Version]
- Li, H.; Yang, T.; Liao, T.; Debowski, A.W.; Nilsson, H.O.; Fulurija, A.; Haslam, S.M.; Mulloy, B.; Dell, A.; Stubbs, K.A.; et al. The redefinition of Helicobacter pylori lipopolysaccharide O-antigen and core-oligosaccharide domains. PLoS Pathog. 2017, 13, e1006280. [Google Scholar] [CrossRef]
- Li, H.; Marceau, M.; Yang, T.; Liao, T.; Tang, X.; Hu, R.; Xie, Y.; Tang, H.; Tay, A.; Shi, Y.; et al. East-Asian Helicobacter pylori strains synthesize heptan-deficient lipopolysaccharide. PLoS Genet. 2019, 15, e1008497. [Google Scholar] [CrossRef]
- Kneidinger, B.; Marolda, C.; Graninger, M.; Zamyatina, A.; McArthur, F.; Kosma, P.; Valvano, M.A.; Messner, P. Biosynthesis pathway of ADP-L-glycero-beta-D-manno-heptose in Escherichia coli. J. Bacteriol. 2002, 184, 363–369. [Google Scholar] [CrossRef] [Green Version]
- Gaudet, R.G.; Sintsova, A.; Buckwalter, C.M.; Leung, N.; Cochrane, A.; Li, J.; Cox, A.D.; Moffat, J.; Gray-Owen, S.D. INNATE IMMUNITY. Cytosolic detection of the bacterial metabolite HBP activates TIFA-dependent innate immunity. Science 2015, 348, 1251–1255. [Google Scholar] [CrossRef] [PubMed]
- Stein, S.C.; Faber, E.; Bats, S.H.; Murillo, T.; Speidel, Y.; Coombs, N.; Josenhans, C. Helicobacter pylori modulates host cell responses by CagT4SS-dependent translocation of an intermediate metabolite of LPS inner core heptose biosynthesis. PLoS Pathog. 2017, 13, e1006514. [Google Scholar] [CrossRef] [Green Version]
- Zimmermann, S.; Pfannkuch, L.; Al-Zeer, M.A.; Bartfeld, S.; Koch, M.; Liu, J.; Rechner, C.; Soerensen, M.; Sokolova, O.; Zamyatina, A.; et al. ALPK1- and TIFA-Dependent Innate Immune Response Triggered by the Helicobacter pylori Type IV Secretion System. Cell. Rep. 2017, 20, 2384–2395. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Pfannkuch, L.; Hurwitz, R.; Traulsen, J.; Sigulla, J.; Poeschke, M.; Matzner, L.; Kosma, P.; Schmid, M.; Meyer, T.F. ADP heptose, a novel pathogen-associated molecular pattern identified in Helicobacter pylori. FASEB J. 2019, 33, 9087–9099. [Google Scholar] [CrossRef] [Green Version]
- Zhou, P.; She, Y.; Dong, N.; Li, P.; He, H.; Borio, A.; Wu, Q.; Lu, S.; Ding, X.; Cao, Y.; et al. Alpha-kinase 1 is a cytosolic innate immune receptor for bacterial ADP-heptose. Nature 2018, 561, 122–126. [Google Scholar] [CrossRef]
- Heine, M.; Cramm-Behrens, C.I.; Ansari, A.; Chu, H.P.; Ryazanov, A.G.; Naim, H.Y.; Jacob, R. Alpha-kinase 1, a new component in apical protein transport. J. Biol. Chem. 2005, 280, 25637–25643. [Google Scholar] [CrossRef] [Green Version]
- Milivojevic, M.; Dangeard, A.S.; Kasper, C.A.; Tschon, T.; Emmenlauer, M.; Pique, C.; Schnupf, P.; Guignot, J.; Arrieumerlou, C. ALPK1 controls TIFA/TRAF6-dependent innate immunity against heptose-1,7-bisphosphate of gram-negative bacteria. PLoS Pathog. 2017, 13, e1006224. [Google Scholar] [CrossRef]
- Kanamori, M.; Suzuki, H.; Saito, R.; Muramatsu, M.; Hayashizaki, Y. T2BP, a novel TRAF2 binding protein, can activate NF-kappaB and AP-1 without TNF stimulation. Biochem. Biophys. Res. Commun. 2002, 290, 1108–1113. [Google Scholar] [CrossRef]
- Huang, C.C.F.; Weng, J.H.; Wei, T.Y.W.; Wu, P.Y.G.; Hsu, P.H.; Chen, Y.H.; Wang, S.C.; Qin, D.; Hung, C.C.; Chen, S.T.; et al. Intermolecular binding between TIFA-FHA and TIFA-pT mediates tumor necrosis factor alpha stimulation and NF-κB activation. Mol. Cell. Biol. 2012, 32, 2664–2673. [Google Scholar] [CrossRef] [Green Version]
- Ea, C.K.; Sun, L.; Inoue, J.; Chen, Z.J. TIFA activates IkappaB kinase (IKK) by promoting oligomerization and ubiquitination of TRAF6. Proc. Natl. Acad. Sci. USA. 2004, 101, 15318–15323. [Google Scholar] [CrossRef] [Green Version]
- Maubach, G.; Lim, M.C.C.; Sokolova, O.; Backert, S.; Meyer, T.F.; Naumann, M. TIFA has dual functions in Helicobacter pylori-induced classical and alternative NF-κB pathways. EMBO Rep. 2021, 22, e52878. [Google Scholar] [CrossRef] [PubMed]
- Merga, Y.J.; O’Hara, A.; Burkitt, M.D.; Duckworth, C.A.; Probert, C.S.; Campbell, B.J.; Pritchard, D.M. Importance of the alternative NF-κB activation pathway in inflammation-associated gastrointestinal carcinogenesis. Am. J. Physiol. Gastrointest. Liver. Physiol. 2016, 310, G1081–G1090. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Faass, L.; Stein, S.C.; Hauke, M.; Gapp, M.; Albanese, M.; Josenhans, C. Contribution of heptose metabolites and the cag pathogenicity island to the activation of monocytes/macrophages by Helicobacter pylori. Front. Immunol. 2021, 12, 632154. [Google Scholar] [CrossRef] [PubMed]
- Jan, H.M.; Chen, Y.C.; Shih, Y.Y.; Huang, Y.C.; Tu, Z.; Ingle, A.B.; Liu, S.W.; Wu, M.S.; Gervay-Hague, J.; Mong, K.K.T.; et al. Metabolic labelling of cholesteryl glucosides in Helicobacter pylori reveals how the uptake of human lipids enhances bacterial virulence. Chem. Sci. 2016, 7, 6208–6216. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Haque, M.; Hirai, Y.; Yokota, K.; Mori, N.; Jahan, I.; Ito, H.; Hotta, H.; Yano, I.; Kanemasa, Y.; Oguma, K. Lipid profile of Helicobacter spp.: Presence of cholesteryl glucoside as a characteristic feature. J. Bacteriol. 1996, 178, 2065–2070. [Google Scholar] [CrossRef] [Green Version]
- Lebrun, A.H.; Wunder, C.; Hildebrand, J.; Churin, Y.; Zähringer, U.; Lindner, B.; Meyer, T.F.; Heinz, E.; Warnecke, D. Cloning of a cholesterol-alpha-glucosyltransferase from Helicobacter pylori. J. Biol. Chem. 2006, 281, 27765–27772. [Google Scholar] [CrossRef] [Green Version]
- Wunder, C.; Churin, Y.; Winau, F.; Warnecke, D.; Vieth, M.; Lindner, B.; Zähringer, U.; Mollenkopf, H.J.; Heinz, E.; Meyer, T.F. Cholesterol glucosylation promotes immune evasion by Helicobacter pylori. Nat. Med. 2006, 12, 1030–1038. [Google Scholar] [CrossRef]
- Nagata, M.; Toyonaga, K.; Ishikawa, E.; Haji, S.; Okahashi, N.; Takahashi, M.; Izumi, Y.; Imamura, A.; Takato, K.; Ishida, H.; et al. Helicobacter pylori metabolites exacerbate gastritis through C-type lectin receptors. J. Exp. Med. 2021, 218, e20200815. [Google Scholar] [CrossRef]
- Smith, K.D.; Andersen-Nissen, E.; Hayashi, F.; Strobe, K.; Bergman, M.A.; Barrett, S.L.R.; Cookson, B.T.; Aderem, A. Toll-like receptor 5 recognizes a conserved site on flagellin required for protofilament formation and bacterial motility. Nat. Immunol. 2003, 4, 1247–1253. [Google Scholar] [CrossRef]
- Gewirtz, A.T.; Yu, Y.; Krishna, U.S.; Israel, D.A.; Lyons, S.L.; Peek, R.M., Jr. Helicobacter pylori flagellin evades toll-like receptor 5-mediated innate immunity. J. Infect. Dis. 2004, 189, 1914–1920. [Google Scholar] [CrossRef] [Green Version]
- Andersen-Nissen, E.; Smith, K.D.; Strobe, K.L.; Barrett, S.L.R.; Cookson, B.T.; Logan, S.M.; Aderem, A. Evasion of Toll-like receptor 5 by flagellated bacteria. Proc. Natl. Acad. Sci. USA 2005, 102, 9247–9252. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Eletto, D.; Vllahu, M.; Mentucci, F.; Del Gaudio, P.; Petrella, A.; Porta, A.; Tosco, A. TFF1 induces aggregation and reduces motility of Helicobacter pylori. Int. J. Mol. Sci. 2021, 22, 1851. [Google Scholar] [CrossRef] [PubMed]
- Tegtmeyer, N.; Neddermann, M.; Lind, J.; Pachathundikandi, S.K.; Sharafutdinov, I.; Gutiérrez-Escobar, A.J.; Brönstrup, M.; Tegge, W.; Hong, M.; Rohde, M.; et al. Toll-like Receptor 5 activation by the cagy repeat domains of Helicobacter pylori. Cell Rep. 2020, 32, 108159. [Google Scholar] [CrossRef] [PubMed]
- Pachathundikandi, S.K.; Tegtmeyer, N.; Arnold, I.C.; Lind, J.; Neddermann, M.; Falkeis-Veits, C.; Chattopadhyay, S.; Brönstrup, M.; Tegge, W.; Hong, M.; et al. T4SS-dependent TLR5 activation by Helicobacter pylori infection. Nat. Commun. 2019, 10, 5717. [Google Scholar] [CrossRef] [Green Version]
- Xu, T.; Fu, D.; Ren, Y.; Dai, Y.; Lin, J.; Tang, L.; Ji, J. Genetic variations of TLR5 gene interacted with Helicobacter pylori infection among carcinogenesis of gastric cancer. Oncotarget 2017, 8, 31016–31022. [Google Scholar] [CrossRef] [Green Version]
- Jeong, Y.S.; Bae, Y.S. Formyl peptide receptors in the mucosal immune system. Exp. Mol. Med. 2020, 52, 1694–1704. [Google Scholar] [CrossRef]
- He, H.Q.; Ye, R.D. The Formyl Peptide Receptors: Diversity of Ligands and Mechanism for Recognition. Molecules 2017, 22, 455. [Google Scholar] [CrossRef]
- Bylund, J.; Christophe, T.; Boulay, F.; Nyström, T.; Karlsson, A.; Dahlgren, C. Proinflammatory activity of a cecropin-like antibacterial peptide from Helicobacter pylori. Antimicrob. Agents Chemother. 2001, 45, 1700–1704. [Google Scholar] [CrossRef] [Green Version]
- De Paulis, A.; Prevete, N.; Rossi, F.W.; Rivellese, F.; Salerno, F.; Delfino, G.; Liccardo, B.; Avilla, E.; Montuori, N.; Mascolo, M.; et al. Helicobacter pylori Hp(2–20) promotes migration and proliferation of gastric epithelial cells by interacting with formyl peptide receptors in vitro and accelerates gastric mucosal healing in vivo. J. Immunol. 2009, 183, 3761–3769. [Google Scholar]
- Capparelli, R.; De Chiara, F.; Nocerino, N.; Montella, R.C.; Iannaccone, M.; Fulgione, A.; Romanelli, A.; Avitabile, C.; Blaiotta, G.; Capuano, F. New perspectives for natural antimicrobial peptides: Application as antinflammatory drugs in a murine model. BMC Immunol. 2012, 13, 61. [Google Scholar]
- Hemmi, H.; Takeuchi, O.; Kawai, T.; Kaisho, T.; Sato, S.; Sanjo, H.; Matsumoto, M.; Hoshino, K.; Wagner, H.; Takeda, K.; et al. A Toll-like receptor recognizes bacterial DNA. Nature 2000, 408, 740–745. [Google Scholar] [CrossRef] [PubMed]
- Wagner, H. The sweetness of the DNA backbone drives Toll-like receptor 9. Curr. Opin. Immunol. 2008, 20, 396–400. [Google Scholar] [CrossRef] [PubMed]
- Ohto, U.; Shibata, T.; Tanji, H.; Ishida, H.; Krayukhina, E.; Uchiyama, S.; Miyake, K.; Shimizu, T. Structural basis of CpG and inhibitory DNA recognition by Toll-like receptor 9. Nature 2015, 520, 702–705. [Google Scholar] [CrossRef] [PubMed]
- Brencicova, E.; Diebold, S.S. Nucleic acids and endosomal pattern recognition: How to tell friend from foe? Front. Cell. Infect. Microbiol. 2013, 3, 37. [Google Scholar] [CrossRef] [Green Version]
- Schmausser, B.; Andrulis, M.; Endrich, S.; Lee, S.K.; Josenhans, C.; Müller-Hermelink, H.K.; Eck, M. Expression and subcellular distribution of toll-like receptors TLR4, TLR5 and TLR9 on the gastric epithelium in Helicobacter pylori infection. Clin. Exp. Immunol. 2004, 136, 521–526. [Google Scholar] [CrossRef]
- Varga, M.G.; Shaffer, C.L.; Sierra, J.C.; Suarez, G.; Piazuelo, M.B.; Whitaker, M.E.; Romero-Gallo, J.; Krishna, U.S.; Delgado, A.; Gomez, M.A.; et al. Pathogenic Helicobacter pylori strains translocate DNA and activate TLR9 via the cancer-associated cag type IV secretion system. Oncogene 2016, 35, 6262–6269. [Google Scholar] [CrossRef] [Green Version]
- Luther, J.; Owyang, S.Y.; Takeuchi, T.; Cole, T.S.; Zhang, M.; Liu, M.; Erb-Downward, J.; Rubenstein, J.H.; Chen, C.C.; Pierzchala, A.V.; et al. Helicobacter pylori DNA decreases pro-inflammatory cytokine production by dendritic cells and attenuates dextran sodium sulphate-induced colitis. Gut 2011, 60, 1479–1486. [Google Scholar] [CrossRef]
- Owyang, S.Y.; Luther, J.; Owyang, C.C.; Zhang, M.; Kao, J.Y. Helicobacter pylori DNA’s anti-inflammatory effect on experimental colitis. Gut. Microbes. 2012, 3, 168–171. [Google Scholar] [CrossRef] [Green Version]
- Rad, R.; Ballhorn, W.; Voland, P.; Eisenächer, K.; Mages, J.; Rad, L.; Ferstl, R.; Lang, R.; Wagner, H.; Schmid, R.M.; et al. Extracellular and intracellular pattern recognition receptors cooperate in the recognition of Helicobacter pylori. Gastroenterology 2009, 136, 2247–2257. [Google Scholar] [CrossRef]
- Guerrero-Mandujano, A.; Hernández-Cortez, C.; Ibarra, J.A.; Castro-Escarpulli, G. The outer membrane vesicles: Secretion system type zero. Traffic 2017, 18, 425–432. [Google Scholar] [CrossRef] [Green Version]
- Tiku, V.; Tan, M.W. Host immunity and cellular responses to bacterial outer membrane vesicles. Trends Immunol. 2021, 42, 1024–1036. [Google Scholar] [CrossRef] [PubMed]
- Grande, R.; Di Marcantonio, M.C.; Robuffo, I.; Pompilio, A.; Celia, C.; Di Marzio, L.; Paolino, D.; Codagnone, M.; Muraro, R.; Stoodley, P.; et al. Helicobacter pylori ATCC 43629/NCTC 11639 Outer Membrane Vesicles (OMVs) from biofilm and planktonic phase associated with extracellular DNA (eDNA). Front. Microbiol. 2015, 6, 1369. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Yonezawa, H.; Osaki, T.; Woo, T.; Kurata, S.; Zaman, C.; Hojo, F.; Hanawa, T.; Kato, S.; Kamiya, S. Analysis of outer membrane vesicle protein involved in biofilm formation of Helicobacter pylori. Anaerobe 2011, 17, 388–390. [Google Scholar] [CrossRef] [PubMed]
- Olofsson, A.; Vallström, A.; Petzold, K.; Tegtmeyer, N.; Schleucher, J.; Carlsson, S.; Haas, R.; Backert, S.; Wai, S.N.; Gröbner, G.; et al. Biochemical and functional characterization of Helicobacter pylori vesicles. Mol. Microbiol. 2012, 77, 1539–1555. [Google Scholar] [CrossRef] [Green Version]
- Keenan, J.I.; Davis, K.A.; Beaugie, C.R.; McGovern, J.J.; Moran, A.P. Alterations in Helicobacter pylori outer membrane and outer membrane vesicle-associated lipopolysaccharides under iron-limiting growth conditions. Innate Immun. 2008, 14, 279–290. [Google Scholar] [CrossRef]
- Turner, L.; Bitto, N.J.; Steer, D.L.; Lo, C.; D’Costa, K.; Ramm, G.; Shambrook, M.; Hill, A.F.; Ferrero, R.L.; Kaparakis-Liaskos, M. Helicobacter pylori outer membrane vesicle size determines their mechanisms of host cell entry and protein content. Front. Immunol. 2018, 9, 1466. [Google Scholar] [CrossRef] [Green Version]
- Viala, J.; Chaput, C.; Boneca, I.G.; Cardona, A.; Girardin, S.E.; Moran, A.P.; Athman, R.; Mémet, S.; Huerre, M.R.; Coyle, A.J.; et al. Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat. Immunol. 2004, 5, 1166–1174. [Google Scholar] [CrossRef]
- Kaparakis, M.; Turnbull, L.; Carneiro, L.; Firth, S.; Coleman, H.A.; Parkington, H.C.; Le Bourhis, L.; Karrar, A.; Viala, J.; Mak, J.; et al. Bacterial membrane vesicles deliver peptidoglycan to NOD1 in epithelial cells. Cell Microbiol. 2010, 12, 372–385. [Google Scholar] [CrossRef] [Green Version]
- Hutton, M.L.; Kaparakis-Liaskos, M.; Turner, L.; Cardona, A.; Kwok, T.; Ferrero, R.L. Helicobacter pylori exploits cholesterol-rich microdomains for induction of NF-kappaB-dependent responses and peptidoglycan delivery in epithelial cells. Infect. Immun. 2010, 78, 4523–4531. [Google Scholar] [CrossRef] [Green Version]
- Allison, C.C.; Kufer, T.A.; Kremmer, E.; Kaparakis, M.; Ferrero, R.L. Helicobacter pylori induces MAPK phosphorylation and AP-1 activation via a NOD1-dependent mechanism. J. Immunol. 2009, 183, 8099–8109. [Google Scholar] [CrossRef] [Green Version]
- Grubman, A.; Kaparakis, M.; Viala, J.; Allison, C.; Badea, L.; Karrar, A.; Boneca, I.G.; Le Bourhis, L.; Reeve, S.; Smith, I.A.; et al. The innate immune molecule, NOD1, regulates direct killing of Helicobacter pylori by antimicrobial peptides. Cell. Microbiol. 2010, 12, 626–639. [Google Scholar] [CrossRef] [PubMed]
- Watanabe, T.; Asano, N.; Fichtner-Feigl, S.; Gorelick, P.L.; Tsuji, Y.; Matsumoto, Y.; Chiba, T.; Fuss, I.J.; Kitani, A.; Strober, W. NOD1 contributes to mouse host defense against Helicobacter pylori via induction of type I IFN and activation of the ISGF3 signaling pathway. J. Clin. Investig. 2010, 120, 1645–1662. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Jarzab, M.; Posselt, G.; Meisner-Kober, N.; Wessler, S. Helicobacter pylori-Derived Outer Membrane Vesicles (OMVs): Role in Bacterial Pathogenesis? Microorganisms 2020, 8, 1328. [Google Scholar] [CrossRef]
- Ismail, S.; Hampton, M.B.; Keenan, J.I. Helicobacter pylori outer membrane vesicles modulate proliferation and interleukin-8 production by gastric epithelial cells. Infect. Immun. 2003, 71, 5670–5675. [Google Scholar] [CrossRef] [Green Version]
- Choi, H.I.; Choi, J.P.; Seo, J.; Kim, B.J.; Rho, M.; Han, J.K.; Kim, J.G. Helicobacter pylori-derived extracellular vesicles increased in the gastric juices of gastric adenocarcinoma patients and induced inflammation mainly via specific targeting of gastric epithelial cells. Exp. Mol. Med. 2017, 49, e330. [Google Scholar] [CrossRef]
- Chitcholtan, K.; Hampton, M.B.; Keenan, J.I. Outer membrane vesicles enhance the carcinogenic potential of Helicobacter pylori. Carcinogenesis 2008, 29, 2400–2405. [Google Scholar] [CrossRef] [Green Version]
- Chmiela, M.; Walczak, N.; Rudnicka, K. Helicobacter pylori outer membrane vesicles involvement in the infection development and Helicobacter pylori-related diseases. J. Biomed. Sci. 2018, 25, 78. [Google Scholar] [CrossRef]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Eletto, D.; Mentucci, F.; Voli, A.; Petrella, A.; Porta, A.; Tosco, A. Helicobacter pylori Pathogen-Associated Molecular Patterns: Friends or Foes? Int. J. Mol. Sci. 2022, 23, 3531. https://doi.org/10.3390/ijms23073531
Eletto D, Mentucci F, Voli A, Petrella A, Porta A, Tosco A. Helicobacter pylori Pathogen-Associated Molecular Patterns: Friends or Foes? International Journal of Molecular Sciences. 2022; 23(7):3531. https://doi.org/10.3390/ijms23073531
Chicago/Turabian StyleEletto, Daniela, Fatima Mentucci, Antonia Voli, Antonello Petrella, Amalia Porta, and Alessandra Tosco. 2022. "Helicobacter pylori Pathogen-Associated Molecular Patterns: Friends or Foes?" International Journal of Molecular Sciences 23, no. 7: 3531. https://doi.org/10.3390/ijms23073531